ARTHROCARE CORP Research and Development Expense
ARTHROCARE CORP reported Research and Development Expense of $8.03 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-05-02
- ARTHROCARE CORP research and development expense for the quarter ending 2014-03-31 was $8.03M, a 4.94% decline year-over-year.
- ARTHROCARE CORP research and development expense for the quarter ending 2013-12-31 was $8.43M, a 0.48% decline year-over-year.
- ARTHROCARE CORP research and development expense for the quarter ending 2013-09-30 was $8.43M, a 3.04% increase year-over-year.
- ARTHROCARE CORP research and development expense for the quarter ending 2013-06-30 was $8.66M, a 9.62% increase year-over-year.
- ARTHROCARE CORP research and development expense for fiscal 2013 was $33.97M, a 5.66% increase from fiscal 2012.
- ARTHROCARE CORP research and development expense for fiscal 2012 was $32.15M, a 11.11% increase from fiscal 2011.
- ARTHROCARE CORP research and development expense for fiscal 2011 was $28.93M, a 19.29% decline from fiscal 2010.
- ARTHROCARE CORP research and development expense for fiscal 2010 was $35.85M, a 1.83% increase from fiscal 2009.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2014-03-31 | $8.03M 10-Q · filed 2014-05-02 | $16.46M derived: sum of 2 quarters · filed 2014-05-02 | $24.89M derived: sum of 3 quarters · filed 2014-05-02 | $33.55M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2013-12-31 | $8.43M 10-K · filed 2014-02-13 | $16.86M derived: sum of 2 quarters · filed 2014-02-13 | $25.52M derived: sum of 3 quarters · filed 2014-02-13 | $33.97M 10-K · filed 2014-02-13 | |
| 2013-09-30 | $8.43M 10-K · filed 2014-02-13 | $17.09M derived: sum of 2 quarters · filed 2014-02-13 | $25.54M 10-Q · filed 2013-10-29 | $34.01M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2013-06-30 | $8.66M 10-K · filed 2014-02-13 | $17.10M 10-Q · filed 2013-08-05 | $25.57M derived: sum of 3 quarters · filed 2014-05-02 | $33.76M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2013-03-31 | $8.45M 10-Q · filed 2014-05-02 | $16.91M derived: sum of 2 quarters · filed 2014-05-02 | $25.10M derived: sum of 3 quarters · filed 2014-05-02 | $33.00M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2012-12-31 | $8.47M 10-K · filed 2014-02-13 | $16.65M derived: sum of 2 quarters · filed 2014-02-13 | $24.55M derived: sum of 3 quarters · filed 2014-02-13 | $32.15M 10-K · filed 2014-02-13 | |
| 2012-09-30 | $8.18M 10-K · filed 2014-02-13 | $16.08M derived: sum of 2 quarters · filed 2014-02-13 | $23.68M 10-Q · filed 2013-10-29 | $31.15M derived: sum of 4 quarters · filed 2014-02-13 | |
| 2012-06-30 | $7.90M 10-K · filed 2014-02-13 | $15.49M 10-Q · filed 2013-08-05 | $22.96M derived: sum of 3 quarters · filed 2014-02-13 | $31.00M derived: sum of 4 quarters · filed 2014-02-13 | |
| 2012-03-31 | $7.59M 10-K · filed 2014-02-13 | $15.07M derived: sum of 2 quarters · filed 2014-02-13 | $23.10M derived: sum of 3 quarters · filed 2014-02-13 | $29.72M derived: sum of 4 quarters · filed 2014-02-13 | |
| 2011-12-31 | $7.47M 10-K · filed 2013-02-14 | $15.51M derived: sum of 2 quarters · filed 2013-02-14 | $22.12M derived: sum of 3 quarters · filed 2013-02-14 | $28.93M 10-K · filed 2014-02-13 | |
| 2011-09-30 | $8.04M 10-K · filed 2013-02-14 | $14.65M derived: sum of 2 quarters · filed 2013-02-14 | $21.46M 10-Q · filed 2012-10-31 | $30.77M derived: sum of 4 quarters · filed 2013-02-14 | |
| 2011-06-30 | $6.61M 10-K · filed 2013-02-14 | $13.42M 10-Q · filed 2012-08-01 | $22.73M derived: sum of 3 quarters · filed 2013-02-14 | $31.98M derived: sum of 4 quarters · filed 2013-02-14 | |
| 2011-03-31 | $6.81M 10-K · filed 2013-02-14 | $16.12M derived: sum of 2 quarters · filed 2013-02-14 | $25.36M derived: sum of 3 quarters · filed 2013-02-14 | $33.78M derived: sum of 4 quarters · filed 2013-02-14 | |
| 2010-12-31 | $9.31M 10-K · filed 2012-02-16 | $18.55M derived: sum of 2 quarters · filed 2012-02-16 | $26.97M derived: sum of 3 quarters · filed 2012-02-16 | $35.85M 10-K · filed 2013-02-14 | |
| 2010-09-30 | $9.24M 10-K · filed 2012-02-16 | $17.66M derived: sum of 2 quarters · filed 2012-02-16 | $26.54M 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | $8.41M 10-K · filed 2012-02-16 | $17.03M 10-Q · filed 2011-08-03 | |||
| 2010-03-31 | $8.88M 10-K · filed 2012-02-16 | $8.62M 10-Q · filed 2011-05-02 | |||
| 2009-12-31 | $35.20M 10-K · filed 2012-02-16 |